Complications of transcatheter aortic valve implantation: Avoidance and management

EuroIntervention

Volumn 7, Issue 5, 2011, Pages 621-628

  Hildick Smith, David ^a   Redwood, Simon ^b   Mullen, Michael ^c   Thomas, Martyn ^b   Kovac, Jan ^d   Brecker, Stephen ^e   Trivedi, Uday ^a   Young, Chris ^b   Hutchinson, Nevil ^a   Maccarthy, Phil ^f   Prendergast, Bernard ^g   De Belder, Mark ^h   Monaghan, Mark ^f   Blackman, Dan ⁱ   Baumbach, Andreas ^j   Manoharan, Ganesh ^k   Moat, Neil ^l  

^a Worthing Hospital   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d GLENFIELD HOSPITAL   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^h JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

ⁱ Leeds Hospital   (United Kingdom)

^j BRISTOL ROYAL INFIRMARY   (United Kingdom)

^k Belfast Hospital   (United Kingdom)

^l ROYAL BROMPTON HOSPITAL   (United Kingdom)

more..

Author keywords

Aortic stenosis; Complications; Transcatheter aortic valve implantation (TAVI)

Indexed keywords

ADRENALIN; DIURETIC AGENT; MILRINONE; NITRATE; VASODILATOR AGENT;

AORTA STENOSIS; AORTA VALVE REGURGITATION; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEART INFARCTION; HEART TAMPONADE; HUMAN; HYPOTENSION; LUNG EDEMA; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; REVIEW; STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; VASCULAR ACCESS;

AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 80055120010     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I5A99     Document Type: Review

References (21)

1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-3008. (Pubitemid 35440280)
2. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
3. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090.
4. Messika-Zeitoun D, Serfaty JM, Brochet E, Ducrocq G, Lepage L, Detaint D, Hyafil F, Himbert D, Pasi N, Laissy JP, Iung B, Vahanian A. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol. 2010;55:186-194.
5. Ng AC, Delgado V, van der Kley F, Shanks M, van de Veire NR, Bertini M, Nucifora G, van Bommel RJ, Tops LF, de Weger A, Tavilla G, de Roos A, Kroft LJ, Leung DY, Schuijf J, Schalij MJ, Bax JJ. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circulation. 2010;3:94-102.
6. Fraccaro C, Napodano M, Tarantini G, Gasparetto V, Gerosa G, Bianco R, Bonato R, Pittarello D, Isabella G, Iliceto S, Ramondo A. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. J Am Coll Cardiol. 2009;2:828-833.
7. Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients. Catheter Cardiovasc Interv. 2010;75:1129-1136.
8. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591-596. (Pubitemid 44202060)
9. Webb JG. Coronary obstruction due to transcatheter valve implantation. Catheter Cardiovasc Interv. 2009;73:973.
10. Webb JG. Strategies in the management of coronary artery disease and transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2009;73:68.
11. Rajani R, Haworth P, Hildick-Smith D. The incidence of nephropathy in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2009;74:662-663.
12. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve. Circulation. 2010;122:62-69.
13. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdary S, Spence M, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder A, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali S, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde J, Hildick-Smith D. Permanent pacemaker insertion following Corevalve transcatheter aortic valve implantation -incidence and contributing factors (the UK Corevalve Collaborative). Circulation. 2011;123:951-960.
14. Haworth P, Behan M, Khawaja M, Hutchinson N, de Belder A, Trivedi U, Laborde JC, Hildick-Smith D. Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;76:751-756.
15. Behan M, Haworth P, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv. 2008;72:1012-1015.
16. Garrett PD, Eckart RE, Bauch TD, Thompson CM, Stajduhar KC. Fluoroscopic localization of the femoral head as a landmark for common femoral artery cannulation. Catheter Cardiovasc Interv. 2005;65:205-207. (Pubitemid 40791513)
17. Khawaja MZ, Haworth P, Ghuran A, Lee L, de Belder A, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol. 2010;55:97-101.
18. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
19. Geisbusch S, Bleiziffer S, Mazzitelli D, Ruge H, Bauernschmitt R, Lange R. Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation. Circulation. 2010;3: 531-536.
20. Rodes-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bedard F, Doyle D, De Larochelliere R, Jayasuria C, Villeneuve J, Marrero A, Cote M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2010;57:18-28.
21. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32: 205-217.